This is a list of terms related to oncology. The original source for this list was the US National Cancer Institute's public domain Dictionary of Cancer Terms.
10-propargyl-10-deazaaminopterin â 12-O-tetradecanoylphorbol-13-acetate â 13-cis retinoic acid â 17-N-allylamino-17-demethoxygeldanamycin â 18F-EF5 â 1H-nuclear magnetic resonance spectroscopic imaging â 2-methoxyestradiol â 2IT-BAD monoclonal antibody 170 â 3-aminopyridine-2-carboxaldehyde thiosemicarbazone â 3-AP â 3-dimensional conformal radiation therapy â 3-dimensional radiation therapy â 4-demethoxydaunorubicin â 4-hydroxytamoxifen â 4-nitroquinoline 1-oxide â 4-NQO â 5-FU â 5-hydroxyindoleacetic acid â 5-hydroxytryptamine â 506U78 â 5Q- syndrome â 6-hydroxymethylacylfulvene â 9-cis retinoic acid â 90Y-DOTA-biotin
A33 monoclonal antibody â AAP â abarelix â ABCD rating â ABI-007 â ABT-510 â ABT-751 â ABX-EGF â accelerated phase â ACE inhibitor â acetylcysteine â achlorhydria â acitretin â acoustic neurofibromatosis â acridine carboxamide â acrylonitrile â actinic keratosis â action study â Activase â acute erythroid leukemia â acute lymphoblastic leukemia â acute lymphocytic leukemia â acute myelogenous leukemia â acute myeloid leukemia â acute nonlymphocytic leukemia â AD 32 â adenocarcinoma â adenoid cystic cancer â adenoma â adenopathy â adenosine triphosphate â adenovirus â adjunct agent â adjunctive therapy â adjuvant therapy â adrenocortical â Adriamycin â adult T-cell leukemia/lymphoma â AE-941 â AEE788 â aerobic metabolism â aerobic respiration â aerodigestive tract â aerosolize â aflatoxin â AFP â AG013736 â AG2037 â AG3340 â AG337 â agent study â agglutinin â aggressive lymphoma â agnogenic myeloid metaplasia â agonist â agranulocytosis â AJCC staging system â alanine aminopeptidase â alanine transferase â alanosine â aldesleukin â alemtuzumab â alendronate sodium â alkalinization â alkylating agent â ALL â all-trans retinoic acid â allogeneic â allogeneic bone marrow transplantation â allogeneic stem cell transplantation â allogenic â allopurinol â Allovectin-7 â aloe-emodin â alopecia â alpha-fetoprotein â Alteplase â altretamine â aluminium sulfate â ALVAC-CEA vaccine â Amanita phalloides â Ambien â amelanotic melanoma â Ames, Bruce â amifostine â amikacin â aminocamptothecin â aminoglutethimide â aminoglycoside antibiotic â aminolevulinic acid â aminopterin â AML â amonafide â amoxicillin â amphotericin B â ampulla â ampulla of Vater â amputation â amsacrine â amylase â amyloidosis â anagrelide â anakinra â anaphylactic shock â anaplastic â anaplastic large cell lymphoma â anaplastic thyroid cancer â anastomosis â anastrozole â androgen â androgen ablation â androgen suppression â androgen-independent â anecdotal report â anemia â anetholtrithione â Angelica root â angiogenesis â angiogenesis inhibitor â angioimmunoblastic T-cell lymphoma â angiosarcoma â angiostatin â angiotensin-converting enzyme inhibitor â anhydrovinblastine â anidulafungin â animal model â annamycin â anorexia â ansamycin â antagonist â anterior mediastinotomy â anterior mediastinum â anthracenedione â anthracycline â anthraquinone â anti-CEA antibody â anti-idiotype vaccine â anti-inflammatory â antiandrogen â antiandrogen therapy â anti-angiogenesis â antiangiogenic â antibody â antibody therapy â anticachexia â anticancer antibiotic â anticarcinogenic â anticoagulant â anticonvulsant â antidepressant â antiemetic â antiestrogen â antifolate â antifungal medication â antigen â antigen-presenting cell â antigen-presenting cell vaccine â antiglobulin test â antihormone therapy â antimetabolite â antimicrotubule agent â antimitotic agent â antineoplastic â antineoplastic antibiotic â antioxidant â antiparasitic â antiretroviral therapy â antisense c-fos â antithymocyte globulin â antituberculosis â antitumor antibiotic â Antiviral drug â anxiolytic â APC â APC vaccine â APC8015 â apheresis â aplastic anemia â aplidine â apocrine gland â apolizumab â apoptosis â appendix â arctigenin â arctiin â arginine butyrate â aromatase inhibitor â arsenic trioxide â arteriogram â arteriography â asbestos â ascites â asparaginase â aspartate transaminase â aspergillosis â Aspergillus â asthenia â astrocyte â astrocytoma â asymptomatic â atamestane â ataxia â ataxia-telangiectasia â ataxic gait â atelectasis â athymic nude mouse â ATLL â ATP â atrasentan â atypical hyperplasia â ATRT atypical teratoid/rhabdoid tumor â augmerosen â autoimmune disease â autologous â autologous bone marrow â autologous bone marrow transplantation â autologous lymphocyte â autologous stem cell transplantation â autologous tumor cell â Avastin â axilla â axillary artery â axillary bud â axillary dissection â axillary lymph node â axillary lymph node dissection â axillary nerve â axillary vein â azacitidine â azoxymethane â AZQ â AZT
B cell â B lymphocyte â B3 antigen â B43-PAP immunotoxin â B7-1 â Bacillus Calmette Guérin â bacterial toxin â barium enema â barium solution â barium swallow â Barrett's esophagus â basal cell â basal cell carcinoma â basal cell nevus syndrome â basophil â batimastat â BAY 12-9566 â BAY 43-9006 â BAY 56-3722 â BAY 59-8862 â BB-10901 â BBBD â BBR 2778 â BBR 3464 â BCG â BCG solution â bcl-2 antisense oligodeoxynucleotide G3139 â BCX-1777 â Beckwith-Wiedemann syndrome â beclomethasone â Bellini duct carcinoma â bendamustine â benign â benign proliferative breast disease â benign prostatic hyperplasia â benign prostatic hypertrophy â benign tumor â benzaldehyde â benzoylphenylurea â benzydamine â Beriplast P â best practice â beta alethine â beta carotene â beta hemolytic streptococcus group B â beta-endorphin â beta-glucan â beta-human chorionic gonadotropin â bevacizumab â bexarotene â Bexxar regimen â BG00001 â BI-RADS â Biafine cream â BIBX 1382 â bicalutamide â bidi (oncology) â bilateral cancer â bilateral nephrectomy â bilateral prophylactic mastectomy â bilateral salpingo-oophorectomy â bile duct â biliary â bilirubin â binding agent â bioavailable â biochanin A â biochemical reactions â biological response modifier â biological therapy â biomarker â Biomed 101 â biopsy â biopsy specimen â biotherapy â BirtâÂÂHoggâÂÂDube syndrome â bispecific antibody â bispecific monoclonal antibody â bisphosphonate â bizelesin â BL22 immunotoxin â black cohosh â black snakeroot â blast â blast crisis â blast phase â bleomycin â blessed thistle â blinded study â blood cell count â blood chemistry study â blood thinner â blood transfusion â bloodâÂÂbrain barrier â bloodâÂÂbrain barrier disruption â BMS-182751 â BMS-184476 â BMS-188797 â BMS-214662 â BMS-247550 â BMS-275291 â BMS-354825 â Bolus (medicine) â bolus infusion â bone marrow â bone marrow ablation â bone marrow aspiration â bone marrow biopsy â bone marrow metastases â bone marrow transplantation â bone metastases â bone scan â bone-seeking radioisotope â Boron neutron capture therapy â boronophenylalanine-fructose complex â bortezomib â Bowen's disease â BPH â brachial plexopathy â brachial plexus â brachytherapy â brain metastasis â brainstem glioma â brain stem tumor â brain tumor â BRCA1 â BRCA2 â breakthrough pain â breast cancer in situ â breast density â breast duct endoscopy â Breast Imaging Reporting and Data System â breast implant â breast reconstruction â breast self-exam â breast-conserving surgery â breast-sparing surgery â Brief Pain Inventory â BRIP1 â brivudine â BRM â bromelain â bronchiole â bronchitis â bronchoscope â bronchoscopy â bronchus â brostallicin â broxuridine â bryostatin 1 â buccal mucosa â budesonide â bupropion â burdock â Burkitt's leukemia â Burkitt's lymphoma â burr hole â buserelin â buspirone â busulfan â buthionine sulfoximine
C cell â c-erbB-2 â c-kit â CA 19-9 assay â CA-125 â CA-125 test â cachexia â calcitonin â calcitriol â CAM â Campath-1H â camptothecin â camptothecin analog â cancer â cancer induction â Cancer Information Service â cancer of unknown primary origin â cancer stem cell â cancer vaccine â Cancer.gov â Candidiasis â Candidosis â CAP-1 â capecitabine â capsaicin â captopril â carbendazim â carbogen â carbon-11 acetate â carboplatin â carboxyamidotriazole â carboxypeptidase-G2 â carcinoembryonic antigen â carcinoembryonic antigen peptide-1 â carcinogen â carcinogenesis â carcinoid â carcinoid syndrome â carcinoma â carcinoma in situ â carcinomatosis â carcinosarcoma â carcinosis â carcinostatic â cardin (oncology) â carmustine â carnitine â carotenoid â carzelesin â case report â case series â case-control study â caspofungin acetate â Castleman's disease â CAT scan â catechol â cauterization â cauterize â cBR96-doxorubicin immunoconjugate â CC-1088 â CC-49 monoclonal antibody â CC-5013 â CC-8490 â CCI-779 â CD34 antigen â CD40-ligand â CEA â CEA assay â cecum â cefalexin â cefepime â cefixime â ceftriaxone â celecoxib â celiac disease â cell â cell differentiation â cell motility â cell proliferation â cell respiration â cell adhesion â cellular adoptive immunotherapy â cellular metabolism â cellulitis â central nervous system primitive neuroectodermal tumor â central venous access catheter â CEP-2563 dihydrochloride â CEP-701 â cephalosporin â ceramide â cerebellar hemangioblastoma â cerebellopontine â cerebral hemisphere â cerebrospinal fluid â cerebrospinal fluid diversion â cervical â cervical intraepithelial neoplasia â cervix â cetuximab â cevimeline â CGP 48664 â Chamberlain procedure â chemoembolization â chemoimmunotherapy â chemoprevention â chemoprevention studies â chemoprotective â chemoradiation â chemoradiotherapy â chemosensitivity â chemosensitivity assay â chemosensitizer â chemotherapeutic agent â chemotherapy â chemotherapy-induced peripheral neuropathy â chest x-ray â chiasma â child-life worker â chitin â chlorambucil â chlorine â chloroma â chloroquinoxaline sulfonamide â cholangiocarcinoma â cholangiosarcoma â cholelith â cholestasis â chondrocyte â chondroitin sulfate â chondrosarcoma â chordoma â chorioallantoic membrane â choriocarcinoma â choroid plexus tumor â CHPP â chronic granulocytic leukemia â chronic idiopathic myelofibrosis â chronic leukemia â chronic lymphoblastic leukemia â chronic lymphocytic leukemia â chronic myelogenous leukemia â chronic myeloid leukemia â chronic myelomonocytic leukemia â chronic phase â chronic phase chronic myelogenous leukemia â CHS 828 â CI-1033 â CI-958 â CI-980 â CI-994 â ciclosporin â cidofovir â cilengitide â cimetidine â Cipro â ciprofloxacin â circulatory system â cirrhosis â CIS â cisplatin â citric acid/potassium-sodium citrate â cladribine â clarithromycin â clear cell adenocarcinoma â clear-cell sarcoma â clear cell sarcoma of the kidney â clinical breast exam â clinical resistance â clinical series â clinical study â clinical trial â CLL â clodronate â clofarabine â CML â CMML â CMV â cnicin â CNS â CNS metastasis â CNS prophylaxis â CNS sanctuary â CNS tumor â co-culture â co-trimoxazole â coactivated T cell â cobalt 60 â Cockayne syndrome â coenzyme Q10 â cohort study â COL-3 â cold nodule â Coley's toxins â collagen disease â collagenase â collecting duct â coloanal anastomosis â coloanal pull-through â Colorectal cancer (colon cancer) â colon polyp â colonoscope â colonoscopy â colony-stimulating factor â colorectal â colposcope â colposcopy â combination chemotherapy â combretastatin A4 phosphate â comedo carcinoma â common bile duct â comorbidity â compassionate use trial â complementary and alternative medicine â complete blood count (CBC) â complete hysterectomy â complete metastasectomy â complete remission â complete response â compound nevus â compression bandage â computed tomographic colonography â computed tomography â computed tomography colography â computerized axial tomography â computerized tomography â concurrent therapy â condylomata acuminata â cone biopsy â congestive heart failure â conization â consecutive case series â consolidation therapy â contiguous lymphoma â continent reservoir â contingency management â continuous hyperthermic peritoneal perfusion â continuous infusion â contralateral â control animal â control group â controlled clinical trial â controlled study â conventional therapy â conventional treatment â cooperative group â CoQ10 â cordectomy â cordycepin â core biopsy â corticosteroid â Corynebacterium granulosum â coumestan â coumestrol â CP-358,774 â CP-609,754 â CP-724,714 â CP4071 â CpG 7909 â CPT 11 â CQS â craniopharyngioma â craniotomy â creatine â creatinine â cribriform â crisnatol mesylate â Crohn's disease â cryopreservation â cryosurgery â cryotherapy â cryptorchidism â CSF â CT scan â CT-2103 â CT-2106 â CT-2584 â CTC â cultured cell â cultured cell line â cumulative dose â curcumin â cutaneous breast cancer â cutaneous T-cell lymphoma â cyanogenic glucoside â cyclooxygenase-2 selective inhibitor â cyclophosphamide â cyclosporine â cyproheptadine â cyproterone acetate â cyst â cystectomy â cystosarcoma phyllodes â cystoscope â cystoscopy â cytarabine â cytochlor â cytogenetics â cytokine â cytology â cytomegalovirus â cytopenia â cytoplasm â cytotoxic â cytotoxic chemotherapy â cytotoxic T cell
D-20761 â da-huang â dacarbazine â dacliximab â daclizumab â dactinomycin â daidzein â dalteparin â danazol â darbepoetin alfa â darkfield microscope â Data Safety and Monitoring Committee â daunorubicin â DCIS â de novo â death cap â debulking operation â decitabine â decortication â deferoxamine â defibrotide â degenerative disease â dehydroepiandrosterone â delayed-type hypersensitivity response â dendritic cell â dendritic cell vaccine â denileukin diftitox â dental implant â deoxycytidine â deoxyribonucleic acid â DepoFoam-encapsulated cytarabine â depsipeptide â dermatofibrosarcoma protuberans â dermatologist â dermis â DES â deslorelin â desmoid tumor â desmoplastic â desmoplastic melanoma â desmoplastic small round cell tumor â dexamethasone â dexmethylphenidate â dexrazoxane â dextroamphetamine-amphetamine â dextromethorphan acetic acid â DFMO â DHA-paclitaxel â DHEA â di-dgA-RFB4 monoclonal antibody â diagnosis â diagnostic mammogram â diagnostic procedures â diagnostic trial â diathermy â diaziquone â didanosine â DIEP flap â diethylstilbestrol â differentiation â difluoromethylornithine â digital mammography â digital photography â digital rectal examination â dihematoporphyrin ether â dimesna â dimethyl sulfoxide â dimethylxanthenone acetic acid â diphosphonate â dipyridamole â disease progression â disease-free survival â disease-specific survival â distal â distal pancreatectomy â distant cancer â distraction â disulfiram â DJ-927 â DNA â docetaxel â dock â dolasetron â dolastatin 10 â donepezil â dose â dose-dense chemotherapy â dose-dependent â dose-limiting â dose-rate â dosimetrist â double-blinded â double-contrast barium enema â doubling time â doxercalciferol â doxorubicin â doxycycline â DRE â dronabinol â drug tolerance â dry orgasm â DTGM fusion protein â ductal carcinoma â ductal carcinoma in situ â ductal lavage â Dukes' classification â dumping syndrome â duodenitis â DX-52-1 â DX-8951f â dyscrasia â dysesthesia â dysgeusia â dysphagia â dysplasia â dysplastic nevi â dysplastic nevus â dyspnea
E7070 â E7389 â EBV â ecchymosis â echocardiography â ecteinascidin 743 â ectocervical â edatrexate â edotecarin â edrecolomab â efaproxiral â effector cell â efficacy â eflornithine â EGb761 â EGFR â EKB-569 â electroacupuncture â electrodesiccation â electrolarynx â electroporation therapy â eligibility criteria â embolism â embolization â embryoma â embryonal rhabdomyosarcoma â embryonal tumor â embryonic â EMD 121974 â emitefur â emodin â enalapril â encephalopathy â enchondroma â endocervical curettage â endocrine cancer â endocrine pancreas cell â endocrine therapy â endometrial â endometrial biopsy â endometrial disorder â endometrial hyperplasia â Endometrial intraepithelial neoplasia â endometriosis â endometrium â endorectal ultrasound â endoscope â endoscopic retrograde cholangiopancreatography â endoscopic ultrasound â endoscopy â endostatin â endothelial cell â endothelin receptor antagonist â endothelin-1 protein receptor antagonists â eniluracil â enoxaparin â ENT â enterostomal therapist â enucleation â enveloped virus â eosinophil â eosinophilia â EP-2101 â ependymal tumor â ependymoma â epidemiology â epidermal growth factor receptor â epidermoid carcinoma â epigastric â epiglottis â epinephrine â epipodophyllotoxin â epirubicin â epithelial â epithelial carcinoma â epithelial ovarian cancer â epithelium â epitope â EPO906 â epoetin alfa â epoetin beta â epothilone â epothilone B â epothilone D â epratuzumab â Epstein-Barr virus â EPT â ER â ER+ â ER- â ERA-923 â erb-38 immunotoxin â ErbB1 â ERCP â erlotinib â ERT â ERUS â erythema â erythrocyte â erythrocyte sedimentation rate â erythrodysplasia â erythroid dysplasia â erythroleukemia â erythroleukoplakia â erythroplakia â erythropoietin â esophageal â esophagectomy â esophagitis â esophagoscopy â esophagram â esophagus â ESR â essential thrombocythemia â essential thrombocytosis â estradiol â estramustine â estramustine phosphate â estrogen â estrogen receptor â estrogen receptor negative â estrogen receptor positive â estrogen receptor test â estrogen replacement therapy â etanercept â etanidazole â ethynyluracil â etidronate â etiology â etoposide â etoposide phosphate â ETS â evaluable disease â evaluable patients â everolimus â Ewing's family of tumors â Ewing's sarcoma â exatecan mesylate â excision â excisional biopsy â exemestane â exisulind â exocrine pancreas cell â expanded access trial â extensive-stage small cell lung cancer â external radiation â external-beam radiation â extrahepatic â extrapleural pneumonectomy
false-negative test result â false-positive test result â familial adenomatous polyposis â familial atypical multiple mole melanoma syndrome â familial cancer â familial dysplastic nevi â familial polyposis â Family history (medicine) â FAMMM syndrome â Fanconi anemia â Fanconi syndrome â FAP â fatty-replaced breast tissue â fazarabine â fecal occult blood test â fenretinide â fentanyl â fiber â fibrin sealant â fibroblast â fibroid â fibromatosis â fibrosarcoma â fibrosis â fibrous â fifth cranial nerve â filgrastim â filgrastim-SD/01 â finasteride â fine-needle aspiration â first-line therapy â FK463 â flavonoid â flavopiridol â flecainide â flow cytometry â floxuridine â flt3L â fluconazole â flucytosine â fludarabine â fludeoxyglucose F 18 â fludrocortisone â fluoropyrimidine â fluoroscope â fluoroscopy â fluorouracil â fluoxetine â flutamide â FOBT â folate â folate antagonist â FOLFOX â folic acid â follicular large cell lymphoma â follicular mixed cell lymphoma â follicular thyroid cancer â formaldehyde â FR901228 â fractionation â free radical â fulguration â fulvestrant â functional magnetic resonance imaging â fundus â fungating lesion â fusion protein
G-CSF â gabapentin â Gail model â gallium nitrate â gallium scan â gamma knife â gamma ray â ganciclovir â ganglioside â gastrectomy â gastric atrophy â gastrinoma â gastroenterologist â gastroesophageal junction â gastroesophageal reflux disease â gastrointestinal â gastrointestinal stromal tumor â gastrointestinal tract â gastroscope â gastroscopy â gefitinib â geldanamycin analog â GEM 231 â gemcitabine â gemtuzumab ozogamicin â gene expression profiling â gene therapy â gene transfer â gene-modified â genetic analysis â genetic counseling â genetic deletion â genetic markers â genetic susceptibility â genetic testing â genistein â genitourinary system â genome â germ cell â germ cell tumor â German Commission E â germinoma â germline mutation â Gerota's capsule â Gerota's fascia â gestational trophoblastic disease â gestational trophoblastic neoplasia â gestational trophoblastic tumor â GI14721 â giant cell fibroblastoma â gimatecan â GIST â Gleason score â Gleevec â Gliadel Wafer â glial cell â glial tumor â glioblastoma â glioblastoma multiforme â glioma â gliosarcoma â glossectomy â glucagon â glucagonoma â glucocorticoid â gluconeogenesis â glufosfamide â glutamine â glutathione â glutathione S-transferase â glycinamide ribonucleotide formyltransferase inhibitor â glycolysis â glycopeptide â glycoprotein â glycoprotein 100 â glycosaminoglycan â GM-CSF â GM2-KLH vaccine â GnRH â gonadotropin-releasing hormone â gonadotropin-releasing hormone agonist â Gonzalez regimen â Gorlin syndrome â goserelin â gossypol â gp100 â gp209-2M â GPX-100 â grade IV astrocytoma â graft-versus-host disease â graft-versus-tumor â granisetron â granulocyte â granulocyte colony-stimulating factor â granulocytic sarcoma â granulocytopenia â granulosa cell tumor - growing teratoma syndrome â GTI-2040 â GVHD â GW572016 â GW786034 â gynecologic â gynecologic cancer â gynecologic oncologist
HAART â hairy cell leukemia â halofuginone hydrobromide â Halsted radical mastectomy â hamartoma â hand-foot syndrome â head and neck cancer â Hedyotis diffusa â HeLa â helical computed tomography â helper T cell â hemagglutinin-neuraminidase â hemangiopericytoma â hemangiosarcoma â hematogenous â hematologic malignancy â hematologist â hematopoiesis â hematopoietic growth factor â hematopoietic tissue â hematoporphyrin derivative â hemilaryngectomy â heparin â hepatectomy â hepatic â hepatic arterial infusion â hepatic artery â hepatic portal vein â hepatic veno-occlusive disease â hepatoblastoma â hepatocellular carcinoma â hepatocyte â hepatoma â hepatomegaly â HER1 â HER2/neu â HER2/neu gene â herba scutellaria barbatae â hereditary leiomyomatosis and renal cell cancer syndrome â hereditary mutation â hereditary nonpolyposis colon cancer â herpesvirus â heterogenic â hexyl 5-aminolevulinate â high-dose chemotherapy â high-dose-rate remote brachytherapy â high-dose-rate remote radiation therapy â high-energy photon therapy â high-grade lymphoma â high grade squamous intraepithelial lesion â high-risk cancer â highly active antiretroviral therapy â hilar â histamine dihydrochloride â histiocytic lymphoma â histologic examination â histology â histone â histone deacetylase â historic cohort study â historical control subject â HLA â HNPCC â Hodgkin's disease â Hodgkin's lymphoma â holmium Ho 166 DOTMP â homoharringtonine â hormonal therapy â hormone receptor â hormone receptor test â hormone replacement therapy â hormone responsive â hormone therapy â Horner's syndrome â host cell â hot nodule â HPPH â HPV â HRT â HTLV-1 â hu14.18-interleukin-2 fusion protein â Huang Lian â human epidermal growth factor receptor 2 â human leukocyte antigen â human lymphocyte antigen â human papillomavirus â human T-cell leukemia virus type 1 â Hürthle cell neoplasm â hydrazine sulfate â hydromorphone â hydronephrosis â hydroureter â hydroxychloroquine â hydroxyurea â hypercalcemia â hyperfractionation â hyperglycemia â hypericum perforatum â hypernephroma â hyperplasia â hypersensitivity â hyperthermia therapy â hyperthermic intraperitoneal chemoperfusion â hyperthermic perfusion â hyperthyroidism â hyperuricemia â hypervascular â hypoglycemia â hypopharynx â hypotension â hypothalamus â hypothesis â hypothyroidism â hypoxia â hypoxic â hysterectomy
ibandronate â ICI 182,780 â ICI D1694 â idarubicin â IDEC-Y2B8 monoclonal antibody â idiopathic â idiopathic myelofibrosis â idoxifene â idoxuridine â ifosfamide â IH636 grape seed extract â IL-1 â IL-1-alfa â IL-11 â IL-12 â IL-2 â IL-3 â IL-4 â IL-6 â ileostomy â iloprost â ILX-295501 â ILX23-7553 â IM-862 â imaging procedure â imatinib mesylate â imipenem â imiquimod â immune adjuvant â immune function â immune response â immune system â immune system tolerance â immunoassay â immunocompetence â immunocompetent â immunocompromised â immunodeficiency â immunodeficiency syndrome â immunoglobulin â immunological adjuvant â immunology â immunomodulation â immunophenotyping â immunoscintigraphy â immunostimulant â immunosuppression â immunosuppressive â immunosuppressive therapy â immunotherapy â immunotoxin â in situ cancer â incisional biopsy â incomplete Freund's adjuvant â indinavir â indium In 111 ibritumomab tiuxetan â indium In 111 pentetreotide â indole-3-carbinol â indolent lymphoma â indometacin â induction therapy â infiltrating cancer â infiltrating ductal carcinoma â inflammatory breast cancer â infliximab â infrared coagulation â inguinal orchiectomy â inoperable â inositol â inositol hexaphosphate â instillation â Institutional Review Board â intensification therapy â Intensity Modulated Radiation Therapy â intercalator â interferon â interleukin â interleukin-1 â interleukin-1-alpha â interleukin-11 â interleukin-12 â interleukin-2 â interleukin-3 â interleukin-4 â interleukin-4 PE38KDEL cytotoxin â interleukin-4 PE38KDEL immunotoxin â interleukin-6 â interleukin-7 â intermediate-grade lymphoma â internal radiation â interstitial radiation therapy â intestinal villi â intoplicine â intracarotid infusion â intracavitary â intracavitary radiation â intracellular â intracolonic â intracranial tumor â intradermal â intraductal carcinoma â intraepithelial â intrahepatic â intrahepatic bile ducts â intrahepatic infusion â intralesional â intraluminal intubation and dilation â Intramuscular injection (IM) â intraocular melanoma â intraoperative radiation therapy â intraperitoneal â intraperitoneal chemotherapy â Intraperitoneal hyperthermic chemoperfusion â intraperitoneal infusion â intraperitoneal radiation therapy â intrapleural â intrathecal â intrathecal chemotherapy â intratumoral, meaning within a tumour â intravenous pyelogram â intravenous pyelography â intraventricular infusion â intravesical â invasive cancer â invasive cervical cancer â inverted papilloma â investigational â inviable â iodine I 131 tositumomab â iododoxorubicin â ionomycin â IORT â Incontinentia pigmenti â IRB â irinotecan â irofulven â irradiated â irradiation â irreversible toxicity â iseganan hydrochloride â ISIS 2503 â ISIS 3521 â ISIS 5132 â islet cell â islet cell cancer â islet of Langerhans cell â isoflavone â isointense â isolated hepatic perfusion â isolated limb perfusion â isolated lung perfusion â isotretinoin â itraconazole â IU â IV â IVP â ixabepilone
J-107088 â J-pouch coloanal anastomosis â jaundice â Jewett staging system â JM 216 â junctional nevus â juvenile myelomonocytic leukemia
Kaposi's sarcoma â karenitecin â Karnofsky Performance Status â keloid â keratan sulfate â keratinocyte growth factor â keratoacanthoma â ketoconazole â ketorolac â keyhole limpet hemocyanin â KGF â killer cell â Kinaret â Klatskin tumor â Klebsiella â Klinefelter syndrome â KOS-862 â KPS â kretek â KRN5500 â KRN7000 â Krukenberg tumor â KW2189
L-377,202 â L-778,123 â L-carnitine (see Carnitine) â laboratory study â laboratory test â lacrimal gland â lactate dehydrogenase â lactic acid dehydrogenase â LAK cell â lamina propria â lamivudine â lamotrigine â laparoscope â laparoscopic prostatectomy â laparoscopic-assisted colectomy â laparoscopy â laparotomy â lappa â large cell carcinoma â large granular lymphocyte â laryngectomy â laser surgery â laser therapy â LCIS â LDH â lectin â leflunomide â leiomyoma â leiomyosarcoma â lentinan â lepirudin â leptomeningeal â leptomeningeal cancer â leptomeningeal metastases â leridistim â lerisetron â Leser-Trélat â letrozole â leucovorin â leukapheresis â leukemia â leukocyte â leukopenia â leukoplakia â leuprorelin â leuvectin â levamisole â levocarnitine â levofloxacin â LGD1069 â LH-RH â Lhermitte's sign â Li-Fraumeni syndrome â liarozole â ligation â light-emitting diode therapy â lignan â limb perfusion â limited-stage small cell lung cancer â linac â liothyronine sodium â lipophilic â liposarcoma â liposomal â lisofylline â Hepatocellular carcinoma (liver cancer) â liver metastases â liver scan â LMB-1 immunotoxin â LMB-2 immunotoxin â LMB-7 immunotoxin â LMB-9 immunotoxin â lobaplatin â lobectomy â lobradimil â lobular carcinoma in situ â lobule â local cancer â local therapy â localized gallbladder cancer â locally advanced cancer â lometrexol â lomustine â lonafarnib â loop electrosurgical excision procedure â loop excision â loperamide hydrochloride â losoxantrone â low-grade lymphoma â lower GI series â LU 79553 â LU-103793 â lubricant â lumbar puncture â lumpectomy â lung metastases â lurtotecan â luteinizing hormone-releasing hormone â luteinizing hormone-releasing hormone agonist â lutetium texaphyrin â LY231514 â LY293111 â LY317615 â LY335979 â LY353381 hydrochloride â lycopene â lymph gland â lymph node â lymph node dissection â lymph node drainage â lymph node mapping â lymph vessel â lymphadenectomy â lymphadenopathy â lymphangiogram â lymphangiography â lymphangiosarcoma â lymphatic fluid â lymphatic mapping â lymphatic system â lymphatic vessel â lymphedema â lymphoblast â lymphocyte â lymphocytic â lymphocytic leukemia â lymphoepithelioma â lymphography â lymphoid â lymphokine-activated killer cell â lymphoma â lymphomatoid granulomatosis â lymphoproliferative disorder â lymphosarcoma â lymphoscintigraphy â Lynch syndrome â lysis â lysosome â lytic â lytic lesion
M protein â macroglobulinemia â macrophage â mafosfamide â MAGE-3 â magnetic resonance imaging â magnetic resonance perfusion imaging â magnetic resonance spectroscopic imaging â magnetic-targeted carrier â maintenance therapy â malabsorption syndrome â malignancy â malignant â malignant ascites â malignant fibrous cytoma â malignant fibrous histiocytoma â malignant meningioma â malignant mesothelioma â malignant mixed Müllerian tumor â malignant peripheral nerve sheath tumor â malondialdehyde â MALT lymphoma â mammary â mammogram â mammography â Mammotome â mantle field â marimastat â mast cell â mastectomy â mastocytoma â matrix metalloproteinase â MDL 101,731 â MDX-060 â mean survival time â measurable disease â mechlorethamine â MEDI-507 â medial supraclavicular lymph node â median survival time â mediastinal pleura â mediastinoscopy â mediastinum â medical castration â medical oncologist â medroxyprogesterone â medullary breast carcinoma â medullary thyroid cancer â medulloblastoma â mega-voltage linear accelerator â megestrol â meiosis â melanocyte â melanoma â melanoma vaccine â melphalan â MEN-10755 â MEN1 syndrome â meningeal â meningeal metastases â meningioma â menopausal hormone therapy â mercaptopurine â mercury â Merkel cell cancer â mesenchymal â mesenteric membrane â mesna â mesonephroma â mesothelioma â metaplasia â metaplastic carcinoma â metastasectomy â metastasis â metastasize â metastatic â metastatic cancer â metasynchronous â meteorism â methotrexate â methoxsalen â Methoxy polyethylene glycol-epoetin beta â methyl-5-aminolevulinate â methylphenidate â methylprednisolone â metoclopramide â metronidazole â metronomic therapy â Mexican valerian â MG98 â microcalcification â micrometastases â micromolar â microsatellite â microsatellite instability â microstaging â microwave therapy â microwave thermotherapy â mifepristone â Miraluma test â misoprostol â mistletoe lectin â mitochondria â mitolactol â mitomycin â mitosis â mitotane â mitotic activity â mitotic index â mitotic inhibitor â mitoxantrone â mivobulin isethionate â mixed glioma â MLN2704 â modafinil â modality â modified radical mastectomy â Mohs surgery â molar pregnancy â molecular risk assessment â molecularly targeted therapy â monoclonal antibody â monoclonal antibody 3F8 â monocyte â Montanide ISA-51 â Morinda citrifolia â morphology â motexafin gadolinium â moxifloxacin â MPNST â MRI â MRSI â MS 209 â MS-275 â mucinous carcinoma â mucosa-associated lymphoid tissue lymphoma â muJ591 monoclonal antibody â Müllerian tumor â multicenter study â multicentric breast cancer â multidrug resistance â multidrug resistance inhibition â multifocal breast cancer â multimodality treatment â multiple endocrine adenomatosis â multiple endocrine neoplasia syndrome â multiple endocrine neoplasia type 1 syndrome â multiple myeloma â multiple sclerosis â multiplicity â muromonab-CD3 monoclonal antibody â musculoskeletal â mycophenolate mofetil â mycosis fungoides â mycostatin â myelin â myeloablation â myelodysplasia â myelodysplastic syndrome â myelofibrosis â myelogenous â myelogram â myeloid â myeloma â myeloproliferative disorder â myelosclerosis with myeloid metaplasia â myelosuppression â myelosuppressive therapy â myometrium
N-acetylcysteine â N-acetyldinaline â N-butyl-N-(4-hydroxybutyl) nitrosamine â naloxone â National Cancer Institute â National Institutes of Health â natural killer cell â NB1011 â NBI-3001 â NCI â nebulizer â neck dissection â needle biopsy â needle-localized biopsy â negative axillary lymph node â negative test result â nelarabine â nelfinavir mesylate â neoadjuvant therapy â neoplasia â neoplasm â nephrotomogram â nephrotoxic â nephroureterectomy â nerve block â nerve grafting â nerve-sparing radical prostatectomy â nerve-sparing surgery â neuro-oncologist â neurobehavioral â neuroblastoma â neuroectodermal tumor â neuroendocrine â neuroendocrine tumor â neuroepithelial â neurofibroma â neurofibromatosis type I â neurofibromatosis type 2 â neuroma â neuron â neuropathologist â neuropathy â neuropeptide â neuroradiologist â neurotoxicity â neurotoxin â neurotropism â neutropenia â neutrophil â nevus â NF1 â NG-monomethyl-L-arginine â niacinamide â nicotinamide â NIH â nilutamide â nimodipine â nipple discharge â nitrocamptothecin â nitrosourea â NK cell â NMRI â node-negative â node-positive â nodular parenchyma â nolatrexed â non-Hodgkin's lymphoma â non-small cell lung cancer (NSCLC) â nonconsecutive case series â noncontiguous lymphoma â nonhematologic cancer â noni â nonlytic â nonmalignant â nonmalignant hematologic disorder â nonmelanoma skin cancer â nonmelanomatous â nonmetastatic â nonopioid â nonprescription â nonrandomized clinical trial â nonseminoma â nonspecific immune cell â nonsteroidal anti-inflammatory drug â nonsteroidal aromatase inhibitor â novobiocin â NPO â NR-LU-10 antigen â NSAID â nuclear magnetic resonance imaging â nuclear medicine scan â nutraceutical â nystatin
O(6)-benzylguanine â oat cell cancer â objective improvement â objective response â oblimersen â obtundation â occult stage non-small cell lung cancer â octreotide â ocular melanoma â ofloxacin â OGX-011 â oblimersen â oligoastrocytoma â oligodendroglial tumor â oligodendroglioma â oltipraz â omega-3 fatty acid â omentectomy â omentum â omeprazole â Ommaya reservoir â oncogene â oncologist â oncology â oncology nurse â oncology pharmacy specialist â oncolysate â oncolysis â oncolytic â Oncolytic virus â Onconase â ondansetron â ONYX-015 â oophorectomy â open biopsy â open colectomy â open label study â opioid â opportunistic infection â oral and maxillofacial surgeon â orchidectomy â orchiectomy â oropharynx â OSI-7904L â osmolality â osteitis deformans â osteogenic sarcoma â osteolytic â osteoporosis â osteosarcoma â ostomy â ovarian ablation â ovarian epithelial cancer â ovarian suppression â Overall Survival (OS) â overexpress â overgrowth syndrome â oxaliplatin â oxandrolone â OXi-104 â oxidative metabolism â oxidative stress
P-32 â p-value â p53 gene â Pacific valerian â paclitaxel â Paget's disease of bone â Paget's disease of the nipple â PALA â palatine uvula â palliative care â palliative therapy â Palmar plantar erythrodysesthesia â pamidronate â Pancoast's tumor â pancreatectomy â pancreatic cancer â pancreatic duct â pancreatic enzyme â pancreatic juice â pancreatitis â PAP, same as Pap smear â Pap smear â Pap test, same as Pap smear â papillary serous carcinoma â papillary thyroid cancer â papillary tumor â papilledema â paracentesis â parageusia â paramyxovirus â paraneoplastic syndrome â parathyroid gland â parathyroid hormone â parenchyma â paresthesias â paricalcitol â parietal pericardium â Parkinson's disease â parotidectomy â paroxetine hydrochloride â partial cystectomy â partial laryngectomy â partial mastectomy â partial nephrectomy â partial oophorectomy â partial remission â partial response â passive antibody therapy â PatersonâÂÂKelly syndrome â pathological staging â patient-controlled analgesia â Patient derived tumor xenografts â PCA â PDQ â peau d'orange â PEG-interferon alfa-2a â PEG-interferon alfa-2b â PEG-MGDF â pegaspargase â pegfilgrastim â PEITC â peldesine â pelvic exenteration â pelvic lymphadenectomy â pemetrexed disodium â penclomedine â penicillamine â pentetic acid calcium â pentosan polysulfate â pentostatin â pentoxifylline â peptide â peptide 946 â percutaneous ethanol injection â percutaneous transhepatic biliary drainage â percutaneous transhepatic cholangiodrainage â percutaneous transhepatic cholangiography â perfusion â perfusion magnetic resonance imaging â pericardial effusion â perifosine â perineal colostomy â perineal prostatectomy â peripheral blood lymphocyte therapy â peripheral neuropathy â peripheral primitive neuroectodermal tumor â peripheral stem cell â peripheral stem cell support â peripheral stem cell transplantation â peristalsis â peritoneal cancer â peritoneal infusion â peritoneal perfusion â pernicious anemia â pertuzumab â PET scan â petechiae â PeutzâÂÂJeghers syndrome â phagocyte â pharmacokinetics â phase I trial â phase I/II trial â phase II trial â phase II/III trial â phase III trial â phase IV trial â phenethyl isothiocyanate â phenoxodiol â phenylacetate â phenylbutyrate â pheochromocytoma â pheresis â Philadelphia chromosome â photodynamic therapy â photothermal therapy â photofrin â photopheresis â phyllodes tumor â Physician Data Query â phytic acid â phytoestrogen â phytosterol â PI-88 â pilocarpine â pilocytic â pineal region tumor â pineoblastoma â pineocytoma â piperacillin/tazobactam â pirfenidone â piritrexim â pixantrone â PJS â PKC412 â plasmacytic â plasmacytoma â plasmapheresis â Plenaxis â pleomorphic â pleural effusion â pleurodesis â plexiform neurofibroma â plexopathy â ploidy â PlummerâÂÂVinson syndrome â pluripotent â pluripotent stem cell â pM-81 monoclonal antibody â PNET â pneumonectomy â PNU 166148 â PNU-93914 â polifeprosan 20 carmustine implant â poly-ICLC â polyglutamate camptothecin â polyglutamate paclitaxel â polymerase chain reaction â polymorphism â polyneuritis â polyp â polypectomy â polyphenol â Polyphenon E â polyposis â pons â pontine â porfimer sodium â porfiromycin â port-a-cath â positive axillary lymph node â positive test result â positron emission tomography scan â postremission therapy â PR+ â PR- â precancerous â precancerous dermatitis â precancerous dermatosis â precancerous polyps â predictive factor â prednisolone â prednisone â preleukemia â premalignant â pretracheal space â prevascular space â preventive mastectomy â primary central nervous system lymphoma â primary endpoint â primary myelofibrosis â primary peritoneal cancer â primary tumor â primitive neuroectodermal tumor â prinomastat â pro-oxidant â probenecid â procarbazine â prochlorperazine â proctoscopy â proctosigmoidoscopy â progesterone receptor negative â progesterone receptor positive â progesterone receptor test â progression-free survival (PFS) â progressive disease â proliferative index â prolymphocytic leukemia â promegapoietin â promyelocytic leukemia â prophylactic cranial irradiation â prophylactic mastectomy â prophylactic oophorectomy â prophylactic surgery â prophylaxis â prospective cohort study â Prost 30 monoclonal antibody â prostate-specific antigen â prostate-specific antigen test â prostatectomy â prostatic acid phosphatase â prostatic intraepithelial neoplasia â prostatitis â protease inhibitor â protein kinase C â proteoglycan â proteomic profile â proteomics â proton beam radiation therapy â proton magnetic resonance spectroscopic imaging â PS-341 â PSA â psammoma body â PSC 833 â pseudomyxoma peritonei â psoralen â PTC â PTCD â PTK787/ZK 222584 â ptosis â pulmonary sulcus tumor â PV701 â pyrazine diazohydroxide â pyrazoloacridine â pyroxamide
Q10 â QS21 â quadrantectomy
R-flurbiprofen â r-tPA â R101933 â R115777 â radiation fibrosis â radiation oncologist â radiation physicist â radiation surgery â radiation therapist â radiation therapy â radical cystectomy â radical lymph node dissection â radical mastectomy â radical perineal prostatectomy â radical prostatectomy â radical retropubic prostatectomy â radioactive drug â radioactive iodine â radioactive palladium â radioactive seed â radiofrequency ablation â radiographer â radioimmunoguided surgery â radioimmunotherapy â radioisotope â radiolabeled â radiologic exam â radionuclide scanning â radiopharmaceutical â radiosensitization â radiosensitizer â radiosurgery â radiotherapy â raloxifene â raltitrexed â randomized clinical trial â ranpirnase â rapamycin â rapid hormone cycling â rapid-onset opioid â ras gene â rasburicase â rattlesnake root â ravuconazole â rebeccamycin â recombinant tissue plasminogen activator â reconstructive surgeon â reconstructive surgery â recurrent cancer â Red blood cell â ReedâÂÂSternberg cell â reflux â refractory cancer â regional cancer â regional chemotherapy â regional enteritis â regional lymph node â regional lymph node dissection â rehabilitation specialist â relative survival rate â relaxation technique â remission induction therapy â remote brachytherapy â renal cell cancer â renal collecting tubule â renal glomerulus â renal tubular acidosis â retinoblastoma â retinoid â retinol â retinyl palmitate â retroperitoneal â retropubic prostatectomy â retrospective cohort study â retrospective study â retroviral vector â retrovirus â RevM10 gene â rhabdoid tumor â rhabdomyosarcoma â rhizoxin â ribavirin â ribonucleotide reductase inhibitor â rifampin â risedronate â ritonavir â rituximab â RK-0202 â RMP-7 â RNA â Ro 31-7453 â Ro 50-3821 â rofecoxib â rosiglitazone â RPI.4610 â RPR 109881A â RSR13 â RSV
S-1 â S-phase fraction â safingol â salpingo-oophorectomy â salvage therapy â samarium 153 â saponin â saquinavir mesylate â sarCNU â sarcoma â sarcosinamide nitrosourea â sargramostim â satraplatin â SC-70935 â SCH 54031 â SCH 66336 â SCH-58500 â Schiller test â Schwann cell â schwannoma â scintimammography â scleroderma â screening mammogram â Scutellaria barbata â SDX-102 â SDX-105 â second primary cancer â second-line therapy â second-look surgery â secondary cancer â sedoxantrone trihydrochloride â segmental cystectomy â segmental mastectomy â selective estrogen receptor modulator â selective serotonin reuptake inhibitor â sella turcica â semaxanib â seminal vesicle biopsy â seminoma â semiparasitic â semustine â senile keratosis â sentinel lymph node â sentinel lymph node biopsy â sentinel lymph node mapping â seocalcitol â SERM â serotonin â sertraline â serum albumin â serum glutamate pyruvate transaminase â Serum glutamic oxaloacetic transaminase â serum tumor marker test â sesquiterpene lactone â sestamibi breast imaging â severe myelosuppression â Sézary syndrome â SGN-00101 â SGN-15 â SGOT â SGPT â sham therapy â shave biopsy â Sho-saiko-to â sialic acid â sialyl Tn-KLH â side-to-end coloanal anastomosis â sideropenic dysphagia â sigmoidoscope â sigmoidoscopy â signal transduction inhibitor â signet ring cell carcinoma â SIL â sildenafil â Silybum marianum â silymarin â simple mastectomy â simple nephrectomy â single blind study â single-photon emission computed tomography â siplizumab â sirolimus â small cell lung cancer â small intestine â smoldering leukemia â smoldering myeloma â SMT-487 â SnET2 â SNX 111 â soblidotin â sodium borocaptate â sodium salicylate â sodium sulfite â sodium thiosulfate â soft tissue sarcoma â solar keratosis â solid tumor â somatic cell â somatic mutation â somnolence syndrome â sonogram â sorivudine â specific immune cell â SPECT â SPF â spiculated mass â spindle cell cancer â spindle cell sarcoma â spiral CT scan â splenomegaly â sputum cytology â squalamine lactate â squamous cell â squamous cell carcinoma â squamous intraepithelial lesion â SR-29142 â SR-45023A â SR49059 â SSRI â staging â staurosporine â stavudine â stellate â stem cell â stem cell factor â stem cell transplantation â stent â stereotactic biopsy â stereotactic body radiation therapy â stereotactic external-beam radiation â stereotactic injection â stereotactic radiation therapy â stereotactic radiosurgery â stereotaxic radiosurgery â stereotaxis â steroid therapy â STI481 â STI571 â stoma â stomatitis â streptavidin â streptozocin â Stromagen â stromal tumor â strontium-89 â SturgeâÂÂWeber syndrome â SU011248 â SU101 â SU5416 â SU6668 â subcutaneous port â subependymal â suberoylanilide hydroxamic acid â subglottis â subset analysis â subtenon â sucralfate â sulfonamide â sulindac â superior vena cava â superior vena cava syndrome â supraclavicular lymph node â supraglottic laryngectomy â supraglottis â supratentorial â suramin â surgical oncologist â survival rate â symptom management â syncytium â syngeneic bone marrow transplantation â syngeneic stem cell transplantation â synovial membrane â synovial sarcoma â synthetic protegrin analog â synthetic retinoid â systemic chemotherapy â systemic disease â systemic lupus erythematosus â systemic therapy
T cell â T-3 â T-cell depletion â T-cell lymphoma â T138067 â T4N5 liposomal lotion â T900607 â TAC-101 â tacrolimus â TAG-72 antigen â talampanel â talaporfin sodium â tamoxifen â tariquidar â taurolidine â taxane â technetium tc 99m dextran â technetium tc 99m sulfur colloid â tegafur â teicoplanin â telangiectasia â temoporfin â temozolomide â teniposide â TENS â teratoma â terminal disease â tetanus toxoid â tetrahydrouridine â TG4010 â theophylline â thermal ablation â thermography â thiotepa â third-line therapy â thoracentesis â thoracoscopy â thoracotomy â thrombocyte â thrombocytopenia â thrombohemorrhagic event â thrombophlebitis â thrombopoietin â thymidine â thymidylate synthase inhibitor â thymoma â Thyrogen â thyroglobulin â thyroid follicular cell â thyroid hormone â thyroid-stimulating hormone â thyroidectomy â thyrotropin alfa â tiazofurin â time to progression â tin ethyl etiopurpurin â tin Sn 117m DTPA â tinidazole â tioguanine â tipifarnib â tirapazamine â tissue plasminogen activator â TLK286 â TM â Transplacental carcinogenesis â TNF â TNFerade â TNM staging system â TNP-470 â tocladesine â tomography â topical chemotherapy â topoisomerase inhibitor â topotecan â toremifene â tositumomab â total androgen blockade â total estrogen blockade â total nodal irradiation â total parenteral nutrition â total-body irradiation â TP-38 immunotoxin â tPA â TPA â trabecular cancer â transabdominal ultrasound â transcutaneous electric nerve stimulation â transdermal â transferrin-CRM107 â transitional cell â transitional cell carcinoma â transperineal biopsy â transrectal biopsy â transrectal ultrasound â transurethral biopsy â transurethral needle ablation â transurethral resection â transurethral resection of the prostate â transvaginal ultrasound â trastuzumab â Traumeel S â treosulfan â tretinoin â triacetyluridine â triamcinolone â Triapine â tributyrin â trichothiodystrophy â triiodothyronine â trimethoprim-sulfamethoxazole â trimetrexate glucuronate â triptorelin â troglitazone â tropisetron â troxacitabine â TRUS â tuberous sclerosis â tubulovillous adenoma â tumor â tumor antigen vaccine â tumor board review â tumor burden â tumor debulking â tumor infiltrating lymphocyte â tumor load â tumor marker â tumor model â tumor necrosis factor â tumor suppressor gene â tumor-derived â tumor-specific antigen â TUR â TURP â TVS â tympany â type I and type II errors â tyrosinase peptide â tyrosine kinase inhibitor â TZT-1027
ubiquinone â UCN-01 â UGT1A1 â ultrasonogram â ultrasonography â ultrasound-guided biopsyâÂÂsee ultrasound and biopsy â ultraviolet radiation therapyâÂÂsee ultraviolet radiation and radiation therapy â uncontrolled studyâÂÂsee clinical trial â unconventional cancer treatmentsâÂÂsee experimental cancer treatment â undifferentiatedâÂÂsee cellular differentiation â unilateral salpingo-oophorectomyâÂÂsee oophorectomy â unresectableâÂÂsee resection â unresectable gallbladder cancerâÂÂsee gallbladder cancer â unsealed internal radiation therapyâÂÂsee radiation therapy â upper GI series â urachus â uracil â urea nitrogenâÂÂsee blood urea nitrogen â ureteroscopy â urine cytologyâÂÂsee urine â urokinase â urologic oncologistâÂÂsee urology and oncologist â urothelium â ursodiol â UV radiation â UVA radiation â UVB radiation â uvula
vaccine adjuvant â vaccine therapy â vaccinia CEA vaccine â vaginal cancer â vaginal melanomaâÂÂvaginal tumors â valacyclovir â valdecoxib â valerian â Valeriana officinalis â Valerianae radix â valganciclovir â valproic acid â vancomycin â vapreotide â varicose veins â vascular endothelial growth factor â VEGF â VEGF Trap â venlafaxine â video-assisted resection â video-assisted surgery â villous adenoma â villus â vinblastine â vinca alkaloid â vincristine â vindesine â vinorelbine â viral vector â virotherapy â virtual colonoscopy â Virulizin â virus replication cycle â virus-neutralizing antibody â viscotoxins â visilizumab â visual pathway glioma â VNP20009 â VNP40101M â von HippelâÂÂLindau disease â voriconazole â vorozole â vulvar cancer â VX 853 â VX-710
Waldenström macroglobulinemia â warfarin â wedge resection â Wermer's syndrome â Whipple procedure â white blood cell â Whitmore-Jewett staging system â whole cell vaccine â Wilms' tumor â Wobe-Mugos E
X-ray â X-ray therapy â xenograft â xeroderma pigmentosum â xerogram â xerostomia â XK469 â XR9576
YM598 â yttrium Y 90 ibritumomab tiuxetan â yttrium Y 90 SMT 487 â yttrium Y 90-DOTA-tyr3-octreotide
ZD 1839 â ZD0473 â ZD6474 â ziconotide â zidovudine â zileuton â zoledronate â ZollingerâÂÂEllison syndrome â Zoloft â zolpidem â zosuquidar trihydrochloride